Patient

P2B-068

completed Phase II

A Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Sarcoma Oncology Center (Santa Monica, CA) (Dr. Reyes)

consented 2013-01-10

Sarcoma Oncology Center (Santa Monica, CA)

Adverse events

Serious AEs

Open data queries

Luna dropout signal

—

not on Luna

Adverse events 3

severe assessed 2013-05-05

Grade 3 nausea with onset in cycle 6 (2013-05-05); assessed as not related to study drug (not related); resolved 2013-05-06.

moderate assessed 2013-03-07

Grade 2 stomatitis with onset in cycle 3 (2013-03-07); assessed as related to study drug (probable); resolved 2013-03-19.

mild assessed 2013-02-02

Grade 1 thrombocytopenia with onset in cycle 1 (2013-02-02); assessed as related to study drug (probable); resolved 2013-02-12.

Data queries 0

No data queries

The CDM sweep raises queries on inconsistent fields.

Luna engagement

This participant doesn't use Luna

Invite them from the site to track mood, adherence and check-ins.

Open Luna users